Yan ke xue bao = Eye science · 1999
[Cyclosporine A and thiotepa in prevention of postoperative recurrence of pterygium].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wu H, Chen G
Аннотация
PURPOSE: To evaluate the efficiency of Cyclosporine A and Thiotepa to decrease the postoperative recurrence rate of pterygium.
METHODS: 50 patients (50 eyes) with pterygium were treated with bare sclera resection and divided into two groups. One group used 1% cyclosporine A eye drops, the other group used 0.05% thiotepa eye drops.
RESULTS: The average follow-up time is 10 months. The recurrence rate of cyclosporine group and thiotepa group is 5% and 10%.
CONCLUSION: Cyclosporine A and Thiotepa can inhibit the hyperplasia of pterygium, and decrease the postoperative recurrence rate.
METHODS: 50 patients (50 eyes) with pterygium were treated with bare sclera resection and divided into two groups. One group used 1% cyclosporine A eye drops, the other group used 0.05% thiotepa eye drops.
RESULTS: The average follow-up time is 10 months. The recurrence rate of cyclosporine group and thiotepa group is 5% and 10%.
CONCLUSION: Cyclosporine A and Thiotepa can inhibit the hyperplasia of pterygium, and decrease the postoperative recurrence rate.